Cigna Corp (CI · NYSE)

CI · MARKET VIEW

Market view · as of Jul 6, 2026

Revenue (TTM)
$277.89B
+4.6% YoY
Gross margin
9.1%
EPS (latest q)
$7.79
vs $7.61 est · beat
52-wk position
64.8%
-8.2% vs 52w high · +6.9% 1mo

Price (last ~year)

Cigna Corp (CI) recently exited major Russell growth indices while maintaining a $76.12 billion market capitalization and reporting a 29.1% year-over-year earnings increase. The company has surpassed earnings estimates for four consecutive quarters, supported by $277.89 billion in trailing twelve-month revenue and a new $100 million AI-powered pharmacy investment. As of March 31, 2026, Cigna held $7.04 billion in cash against $30.90 billion in total debt, with a current P/E ratio of 12.19.

Valuation

Market cap
$76.12B
P/E
12.19
PEG
0.861
P/B
1.804
P/S
0.274
EV/EBITDA
7.9
Beta
0.303
Analyst target
$340.5

Quality & returns

Gross margin
9.1%
Operating margin
5.5%
Profit margin
2.3%
ROE
16.3%
ROA
4.8%

Price movement

Last
$287.77
1-month
+6.9%
3-month
+5.5%
RSI (14)
43
vs SMA200
+3.6%
52-wk position
64.8% -8.2% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$68.49B$2.36B$1.65B$3.28B
2025-12-31$72.47B$2.15B$1.23B$2.54B
2025-09-30$69.75B$2.58B$1.87B$3.34B
2025-06-30$67.23B$2.43B$1.53B$3.04B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots